Survey of moniliformin in corn cultivated in the state of Sao Paulo and in corn products commercialized in the city of Campinas, SP

Moniliformin, a toxin produced by Fusarium, was investigated in 22 samples of corn, 17 coming from districts of the state of Sao Paulo and 4 from experimental plots of the Campinas Institute of Agronomy, Brazil. The toxin was also investigated in 68 samples of corn products commercialized in Campinas, SP. Moniliformin was not detected in any sample.341131

Ochratoxin A in Brazilian roasted and instant coffees

Thirty-four samples of roast and ground coffee, 14 samples of instant coffee and two samples of decaffeinated instant coffee were collected in markets and supermarkets in the city of Campinas, Brazil, and analysed for ochratoxin A using immunoaffinity columns for clean-up and HPLC with fluorescence detection for quantification. The limit of detection was 0.2 ng/g ochratoxin A. Twenty-three samples of ground and roast coffee were found to be contaminated with the toxin at levels ranging between 0.3 and 6.5 ng/g. The average concentration in all 34 samples was 0.9 ng/g. All samples of instant coffee contained ochratoxin A at levels ranging from 0.5 to 5.1 ng/g, with an average figure of 2.2 ng/g. Roast and ground coffee is the type of coffee most used by Brazilians for the preparation of the beverage. Considering that an average Brazilian adult takes five cups of coffee per day, which corresponds to 30 g of roast and ground coffee, the probable daily intake of ochratoxin A by a 70 kg adult would be 0.4 ng/kg bw, which is far below the current Provisional Tolerable Daily Intake of 14 ng/kg bw for ochratoxin A as set by the Codex Alimentarius. To study the transfer of ochratoxin A into coffee brew, the beverage was prepared by two methods : (a) the drip method and (b) the Brazilian country style method. No significant difference was observed between the two methods in terms of extraction of the toxin using five contaminated samples containing between 0.8 and 6.5 ng/g ochratoxin A. The drip method extracted 86 +/- 15 % and the Brazilian country style 74 +/- 20 % of the ochratoxin A initially present in the roast and ground coffee.171086787

International Competition Museo Betile_Mostra Progetti Finalisti_2006

MOSTRA DEI 9 PROGETTI FINALISTI DEL CONCORSO DI PROGETTAZIONE PER LA REALIZZAZIONE DEL MUSEO DELL’ARTE NURAGICA E DELL’ARTE CONTEMPORANEA DEL MEDITERRANE

Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer.

Contains fulltext : 97964.pdf (publisher's version ) (Open Access)This issue of Molecular Medicine contains 14 original research reports and state-of-the-art reviews on histone deacetylase inhibitors (HDACi's), which are being studied in models of a broad range of diseases not related to the proapoptotic properties used to treat cancer. The spectrum of these diseases responsive to HDACi's is for the most part due to several antiinflammatory properties, often observed in vitro but importantly also in animal models. One unifying property is a reduction in cytokine production as well as inhibition of cytokine postreceptor signaling. Distinct from their use in cancer, the reduction in inflammation by HDACi's is consistently observed at low concentrations compared with the higher concentrations required for killing tumor cells. This characteristic makes HDACi's attractive candidates for treating chronic diseases, since low doses are well tolerated. For example, low oral doses of the HDACi givinostat have been used in children to reduce arthritis and are well tolerated. In addition to the antiinflammatory properties, HDACi's have shown promise in models of neurodegenerative disorders, and HDACi's also hold promise to drive HIV-1 out of latently infected cells. No one molecular mechanism accounts for the non-cancer-related properties of HDACi's, since there are 18 genes coding for histone deacetylases. Rather, there are mechanisms unique for the pathological process of specific cell types. In this overview, we summarize the preclinical data on HDACi's for therapy in a wide spectrum of diseases unrelated to the treatment of cancer. The data suggest the use of HDACi's in treating autoimmune as well as chronic inflammatory diseases

"9"8_4_8Cd_5_0 - The two-proton hole spectrum in "1"0"0_5_0Sn_5_0

Excited states in "9"8Cd, two proton holes from "1"0"0Sn, were identified and studied for the first time, using in-beam spectroscopy with highly selective ancillary detectors. The structure of the (#pi#g_9_/_2)"-"2 two proton hole spectrum below a T_1_/_2=0.48(16) #mu#s isomer is deduced and compared to shell model predictions. A tentative I"#pi#=(8"+) assignment, as suggested by systematics, yields a strongly reduced B(E2.8"+#->#6"+)=0.44(_-_1_0"+"2"0) W.u., corresponding to an effective proton charge of #epsilon#_#pi#=0.85(_-_1_0"+"2"0) #epsilon#, which is at variance with existing theoretical predictions. (orig.)Available from FIZ Karlsruhe / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische InformationsbibliothekSIGLEDEGerman